Wild-type heat shock transcription factor 1 (Hsf1wt) suppresses HSP induction by Hsp90 inhibitors. (A) Motor neurons were microinjected with hsp70–green fluorescent protein (GFP) and were immediately treated with three different Hsp90 inhibitors. GFP expression was analyzed 24 hours after microinjection. hsp70-GFP plasmid was microinjected and cultures were treated with 0.01% dimethylsulfoxide (DMSO) vehicle as a negative control (i, ii) or comicroinjected with plasmid encoding constitutively active Hsf1 (Hsf1act) as a positive control (iii, iv). Motor neurons injected with hsp70-GFP plasmid were treated with 0.1 μM geldanamycin (v, vi), 5 μM 17-allylamino-17-demethoxygeldanamycin (17-AAG) (vii, viii), and 5 μM radicicol (ix, x). Coordinate expression of Hsp70 was assessed by immunocytochemistry (ii, iv, vi, viii, x). Induction of both GFP and Hsp70 was observed with each chemical. Arrows indicate the position of a motor neuron treated with DMSO and immunolabeled for Hsp70. Scale bar: 50 μm. (B) Motor neurons were microinjected with plasmid encoding either GFP or Hsf1wt and treated with 2.5 μM 17-AAG for 16 hours beginning 48 hours after injection. Hsp70 induction was detected in 80.7 ± 8.5% of GFP-expressing motor neurons and 63.7 ± 9.4% of these had moderate to robust Hsp70 immunolabeling (table). Only 25.5 ± 22.1% of motor neurons expressing Hsf1wt had detectable Hsp70 in the cytoplasm and immunolabeling was very weak in all of these (*P < 0.005; t-test, data passed normality test). Hsp70 immunolabeling of representative motor neurons expressing GFP (i, ii) (moderate induction) or Hsf1wt (iii, iv) (no induction). Nuclear labeling in (iv) is an artifact of double-immunolabeling with rat and mouse antibodies that is observed when Hsf1 expression is very high and was described previously (Batulan et al. 2006). Scale bar: 50 μm. (C) Motor neurons were microinjected with either hsp70-GFP plasmid alone or in combination with hsf1wt and treated with 2.5 μM 17-AAG for 16 hours beginning 24 hours after injection. Average pixel intensity was calculated for GFP expression in all injected motor neurons identified with a dextran-tetramethylrhodamine marker and the mean of these values was reduced by approximately one-half in those expressing Hsf1wt (*P < 0.005; Mann Whitney log rank test). Approximately one-third of motor neurons with hsp70-GFP alone had an average GFP intensity above a level that appeared qualitatively robust (average pixel intensity > 500), whereas only one motor neuron in the group injected with hsf1wt had strong GFP expression. (D) Hsf1−/− Mouse embryonic fibroblasts (MEFs) were transfected with hsf1wt, hsf1inact, or hsf1act constructs. Beginning 48 hours after transfection, MEFs were heat shocked at 43°C for 1 hour, followed by recovery incubation for 6 hours at 37°C/5% CO2. Expression of Hsf1 and Hsp70 was assessed, and only cells expressing Hsf1wt and Hsf1act expressed Hsp70 by immunocytochemistry. Arrows indicate dominant-negative, inactivatible Hsf1–(Hsf1inact) expressing cells co-immunolabeled for Hsp70. Scale bar: 20 μm. (E) Hsf1+/+ MEFs were mock-transfected or transfected with hsf1wt and, after 48 hours, were heat shocked at 43°C for 1 hour, followed by recovery incubation for 6 hours at 37°C/5% CO2. Mock-transfected MEFs positively labeled for endogenous Hsf1 (i) and Hsp70 (ii) following heat shock to confirm the presence of murine Hsf1. Expression of Hsf1wt was nuclear (iii), as in motor neurons, but this did not prevent induction of Hsp70 when combined with heat shock (iv). Cytoplasmic labeling of Hsp70 outside of the regions where Hsf1wt was expressed confirmed that this immunolabeling was not an artifact of rat and mouse antibody double-immunolabeling. Scale bar: 20 μm